Maram Habashi
Overview
Explore the profile of Maram Habashi including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
3
Citations
21
Followers
0
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Habashi M, Chauhan P, Vutla S, Senapati S, Diachkov M, El-Husseini A, et al.
J Med Chem
. 2023 Feb;
66(4):3058-3072.
PMID: 36763536
Transient soluble oligomers of amyloid-β (Aβ) are considered among the most toxic species in Alzheimer's disease (AD). Soluble Aβ oligomers accumulate early prior to insoluble plaque formation and cognitive impairment....
2.
Habashi M, Vutla S, Tripathi K, Senapati S, Chauhan P, Haviv-Chesner A, et al.
Proc Natl Acad Sci U S A
. 2022 Nov;
119(49):e2210766119.
PMID: 36442093
Transient soluble oligomers of amyloid-β (Aβ) are toxic and accumulate early prior to insoluble plaque formation and cognitive impairment in Alzheimer's disease (AD). Synthetic cyclic D,L-α-peptides (e.g., ) self-assemble into...
3.
Leshem G, Richman M, Lisniansky E, Antman-Passig M, Habashi M, Graslund A, et al.
Chem Sci
. 2019 Feb;
10(1):208-217.
PMID: 30713632
The self-assembly of Aβ to β-sheet-rich neurotoxic oligomers is a main pathological event leading to Alzheimer's disease (AD). Selective targeting of Aβ oligomers without affecting other functional proteins is therefore...